Endosc Int Open 2015; 03(02): E113-E117
DOI: 10.1055/s-0034-1390797
Original article
© Georg Thieme Verlag KG Stuttgart · New York

Efficacy of short period, low dose oral prednisolone for the prevention of stricture after circumferential endoscopic submucosal dissection (ESD) for esophageal cancer

Mikinori Kataoka
1   Department of Gastroenterology and Hepatology, International University of Health and Welfare Mita Hospital, Tokyo, Japan
,
Sho Anzai
1   Department of Gastroenterology and Hepatology, International University of Health and Welfare Mita Hospital, Tokyo, Japan
,
Tomoaki Shirasaki
1   Department of Gastroenterology and Hepatology, International University of Health and Welfare Mita Hospital, Tokyo, Japan
,
Hidekazu Ikemiyagi
1   Department of Gastroenterology and Hepatology, International University of Health and Welfare Mita Hospital, Tokyo, Japan
,
Takashi Fujii
1   Department of Gastroenterology and Hepatology, International University of Health and Welfare Mita Hospital, Tokyo, Japan
,
Kazuhisa Mabuchi
1   Department of Gastroenterology and Hepatology, International University of Health and Welfare Mita Hospital, Tokyo, Japan
,
Shinji Suzuki
1   Department of Gastroenterology and Hepatology, International University of Health and Welfare Mita Hospital, Tokyo, Japan
,
Masashi Yoshida
2   Department of Gastroenterological Surgery, International University of Health and Welfare Mita Hospital, Tokyo, Japan
,
Takashi Kawai
3   Endoscopy Center, Tokyo Medical University Hospital, Tokyo, Japan
,
Masaki Kitajima
2   Department of Gastroenterological Surgery, International University of Health and Welfare Mita Hospital, Tokyo, Japan
› Author Affiliations
Further Information

Publication History

submitted 24 March 2014

accepted after revision 25 September 2014

Publication Date:
29 October 2014 (online)

Background and aims: Endoscopic submucosal dissection (ESD) was developed in Japan and has been performed on many patients with early stage esophageal cancer; however quality of life in patients with postoperative stricture is drastically decreased and repeat, periodic endoscopic balloon dilatation (EBD) is usually required over long periods. In this study, we evaluate the efficacy of short period, low dose oral prednisolone in controlling post-procedural esophageal stricture.

Patients and methods: In total, 33 patients who underwent semicircular or complete circular ESD for esophageal superficial squamous cell carcinoma were included in this study. They were divided into two groups: those who underwent large-circumference ESD with no preventative treatment for stricture (ESD alone group) and those who received systemic steroid treatment for stricture (oral prednisolone group). We compared the two groups in terms of stricture rate and total number of EBD sessions. The ESD alone group underwent no preventative treatment. The oral prednisolone group started with 30 mg/day prednisolone on the second day post-ESD, and continued with a gradually tapering prednisolone dose, finally discontinuing systemic steroid administration 3 weeks later.

Results: The stricture rate after ESD was significantly lower in the oral prednisolone group (3 of 17 patients; 17.6 %) than in the ESD alone group (11 of 16 patients; 68.7 %) (P < 0.01). The number of EBD sessions was significantly lower in the oral prednisolone group than in the ESD alone group (median 4.6, range 2 – 10 vs. median 8.1, range 1 – 18; P < 0.01).

Conclusion: Short period, low dose oral prednisolone showed promising results for the prevention of stricture after ESD for early stage esophageal cancers.

 
  • References

  • 1 Oyama T, Tomori A, Hotta K et al. Endoscopic submucosal dissection of early esophageal cancer. Clin Gastroenterol Hepatol 2005; 3: 67-70
  • 2 Ono S, Fujishiro M, Niimi K et al. Long-term outcomes of endoscopic submucosal dissection for superficial esophageal squamous cell neoplasms. Gastrointest Endosc 2009; 70: 860-866
  • 3 Ono S, Fujishiro M, Niimi K et al. Predictors of postoperative stricture after esophageal endoscopic submucosal dissection for superficial squamous cell neoplasms. Endoscopy 2009; 41: 661-665
  • 4 Katada C, Muto M, Manabe T et al. Esophageal stenosis after endoscopic mucosal resection of superficial esophageal lesion. Gastrointest Endosc 2003; 57: 165-169
  • 5 Fujishiro M, Yahagi N, Kakushima N et al. En bloc resection of a large semicircular esophageal cancer by endoscopic submucosal dissection. Surg Laparosc Endosc Percutan Tech 2006; 16: 237-241
  • 6 Ezoe Y, Muto M, Horimatsu T et al. Efficacy of preventive endoscopic balloon dilation for esophageal stricture after endoscopic resection. J Clin Gastroenterol 2011; 45: 222-227
  • 7 Yoda Y, Yano T, Kaneda K et al. Endoscopic balloon dilatation for benign fibrotic strictures after curative nonsurgical treatment for esophageal cancer. Surg Endosc 2012; 26: 2877-2883
  • 8 Kochhar R, Makharia GK. Usefulness of intralesional triamcinolone in treatment of benign esophageal strictures. Gastrointest Endosc 2002; 56: 829-834
  • 9 Hashimoto S, Kobayashi M, Yakeuchi M et al. The efficacy of endoscopic triamcinolone injection for the prevention of esophageal stricture after endoscopic submucosal dissection. Gastrointest Endosc 2011; 74: 1389-1393
  • 10 Hanaoka N, Ishihara R, Takeuchi N et al. Intralesional steroid injection to prevent stricture after endoscopic submucosal dissection for esophageal cancer: a controlled prospective study. Endoscopy 2012; 44: 1007-1011
  • 11 Morikawa N, Honna T, Kuroda T et al. High dose intravenous methylprednisolone resolves esophageal stricture resistant to balloon dilation with intralesional injection of dexamethasone. Pediatr Surg Int 2008; 24: 1161-1164
  • 12 Hishiki T, Kouchi K, Saito T et al. Successful treatment of severe refractory anastomotic stricture in an infant after esophageal atresia repair by endoscopic balloon dilation combined with systematic administration of dexamethasone. Pediatr Surg Int 2009; 25: 531-533
  • 13 Yamaguchi N, Isomoto H, Nakayama T et al. Usefulness of oral prednisolone in the treatment of esophageal stricture after endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma. Gastrointest Endosc 2011; 73: 1115-1121
  • 14 Takubo K, Aida J, Sawada M et al. Early squamous cell carcinoma of oesophagus; the Japanese view point. Histopathology 2007; 51: 733-742
  • 15 American Society for Gastrointestinal Endoscopy. The Paris endoscopic classification of superficial neoplastic lesions: esophagus, stomach, and colon: November 30 to December 1, 2002. Gastrointest Endosc 2003; 58 (Suppl. 06) 3-43
  • 16 Fujishiro M. Perspective on the practical indication of endoscopic submucosal dissection of gastrointestinal neoplasms. World J Gastroenterol 2008; 14: 4289-4295
  • 17 Ono S, Kodashima S, Fujishiro M et al. Clinical outcomes of endoscopic submucosal dissection for esophageal squamous carcinoma (in Japanese). Stomach Intest 2009; 44: 345-358
  • 18 Sato H, Inoue H, Kobayashi Y et al. Control of severe strictures after circumferential endoscopic submucosal dissection for esophageal carcinoma: oral steroid therapy with balloon dilation or balloon dilation alone. Gastrointest Endosc 2013; 78: 250-257
  • 19 Gaujoux-Viala C, Dougados M, Gossec L. Efficacy and safety of steroid injections for shoulder and elbow tendonitis: a meta-analysis of randomised controlled trials. Ann Rheum Dis 2009; 68: 1843-1849
  • 20 Sarnes E, Crofford L, Watson M et al. Incidence and US costs of corticosteroid-associated adverse events: a systematic literature review. Clin Ther 2011; 33: 1413-1432
  • 21 Stuck AE, Minder CE, Frey FJ. Risk of infectious complications in patients taking glucocorticosteroids. Rev Infect Dis 1989; 11: 954-963
  • 22 Miyashita M, Onda M, Okawa K et al. Endoscopic dexamethasone injection following balloon dilatation of anastomotic stricture after esophagogastrostomy. Am J Surg 1997; 174: 442-444